Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J MacFadyen

Showing results (131-140 of 163) with videos related to

Pageof 17
Sort By:
Journal of Thrombosis and Haemostasis : JTH|December 13, 2006
Circulating endothelial cells and von Willebrand factor as indices of endothelial damage/dysfunction in coronary artery disease: a comparison of central vs. peripheral levels and effects of coronary angioplastyC J Boos, R J Jaumdally, R J MacFadyen, et al.
European Journal of Clinical Investigation|January 11, 2005
Tissue inhibitor of metalloproteinse-1 is a marker of diastolic dysfunction using tissue doppler in patients with type 2 diabetes and hypertensionM H Tayebjee, H S Lim, S Nadar, et al.
Clinical Cardiology|April 9, 2009
Markers of thrombosis and hemostasis in acute coronary syndromes: relationship to increased heart rate and reduced heart-rate variabilityAli Hamaad, Michael D Sosin, Andrew D Blann, et al.
Journal of Internal Medicine|February 20, 2009
Effects of coronary artery disease and percutaneous intervention on the cardiac metabolism of nonesterified fatty acids and insulin: Implications of diabetes mellitusR J Jaumdally, G Y H Lip, J V Patel, et al.
British Journal of Clinical Pharmacology|August 1, 1991
Transpulmonary pharmacokinetics of an ACE inhibitor (perindoprilat) in manR J MacFadyen, K R Lees, J D Gemmill, et al.
Annals of Medicine|October 16, 2007
Indices of angiogenesis, platelet activation, and endothelial damage/dysfunction in relation to ethnicity and coronary artery disease: differences in central versus peripheral levelsRumi J Jaumdally, Chetan Varma, Andrew D Blann, et al.
Chest|October 3, 2007
Platelet activation in coronary artery disease: intracardiac vs peripheral venous levels and the effects of angioplastyRumi J Jaumdally, Chetan Varma, Andrew D Blann, et al.
Cardiovascular Therapeutics|February 12, 2009
Generalized obesity but not that characterized by raised waist-hip ratio is associated with increased perceived breathlessness during treadmill exercise testingDeepak Goyal, Ing-Marie Logie, Sunil K Nadar, et al.
Heart (British Cardiac Society)|June 23, 1999
How often are angiotensin II and aldosterone concentrations raised during chronic ACE inhibitor treatment in cardiac failure?R J MacFadyen, A F Lee, J J Morton, et al.
Journal of Cardiovascular Pharmacology|May 1, 1993
Dose-ranging study of the angiotensin type I receptor antagonist losartan (DuP753/MK954), in salt-deplete normal manJ K Doig, R J MacFadyen, C S Sweet, et al.
Pageof 17

Showing results (131-140 of 163) with videos related to

Sort By:
Pageof 17
Journal of Thrombosis and Haemostasis : JTH|December 13, 2006
Circulating endothelial cells and von Willebrand factor as indices of endothelial damage/dysfunction in coronary artery disease: a comparison of central vs. peripheral levels and effects of coronary angioplastyC J Boos, R J Jaumdally, R J MacFadyen, et al.
European Journal of Clinical Investigation|January 11, 2005
Tissue inhibitor of metalloproteinse-1 is a marker of diastolic dysfunction using tissue doppler in patients with type 2 diabetes and hypertensionM H Tayebjee, H S Lim, S Nadar, et al.
Clinical Cardiology|April 9, 2009
Markers of thrombosis and hemostasis in acute coronary syndromes: relationship to increased heart rate and reduced heart-rate variabilityAli Hamaad, Michael D Sosin, Andrew D Blann, et al.
Journal of Internal Medicine|February 20, 2009
Effects of coronary artery disease and percutaneous intervention on the cardiac metabolism of nonesterified fatty acids and insulin: Implications of diabetes mellitusR J Jaumdally, G Y H Lip, J V Patel, et al.
British Journal of Clinical Pharmacology|August 1, 1991
Transpulmonary pharmacokinetics of an ACE inhibitor (perindoprilat) in manR J MacFadyen, K R Lees, J D Gemmill, et al.
Annals of Medicine|October 16, 2007
Indices of angiogenesis, platelet activation, and endothelial damage/dysfunction in relation to ethnicity and coronary artery disease: differences in central versus peripheral levelsRumi J Jaumdally, Chetan Varma, Andrew D Blann, et al.
Chest|October 3, 2007
Platelet activation in coronary artery disease: intracardiac vs peripheral venous levels and the effects of angioplastyRumi J Jaumdally, Chetan Varma, Andrew D Blann, et al.
Cardiovascular Therapeutics|February 12, 2009
Generalized obesity but not that characterized by raised waist-hip ratio is associated with increased perceived breathlessness during treadmill exercise testingDeepak Goyal, Ing-Marie Logie, Sunil K Nadar, et al.
Heart (British Cardiac Society)|June 23, 1999
How often are angiotensin II and aldosterone concentrations raised during chronic ACE inhibitor treatment in cardiac failure?R J MacFadyen, A F Lee, J J Morton, et al.
Journal of Cardiovascular Pharmacology|May 1, 1993
Dose-ranging study of the angiotensin type I receptor antagonist losartan (DuP753/MK954), in salt-deplete normal manJ K Doig, R J MacFadyen, C S Sweet, et al.
Pageof 17